US Patent Issued to JIANGSU HENGRUI PHARMACEUTICALS, SHANGHAI HENGRUI PHARMACEUTICAL on Sept. 1 for "Pharmaceutical compositions comprising an anti-claudin 18.2 antibody-drug conjugate and method of use thereof to treat a tumor or cancer" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,899, issued on Sept. 1, was assigned to JIANGSU HENGRUI PHARMACEUTICALS Co. LTD. (Lianyungang, China) and SHANGHAI HENGRUI PHARMACEUTICAL Co. LTD. (Shanghai).

"Pharmaceutical compositions comprising an anti-claudin 18.2 antibody-drug conjugate and method of use thereof to treat a tumor or cancer" was invented by Zhiwan Wang (Shanghai), Tingting Wu (Shanghai) and Xun Liu (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are a pharmaceutical composition comprising an antibody-drug conjugate, and use of the pharmaceutical composition. Specifically provided is a pharmaceutical composition, comprising an anti-claudin antibody-drug conjuga...